GSK: latest news, analysis and trading updates | ESM Magazine

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

Haleon To Sell ChapStick To Yellow Wood For About €468m

Britain's Haleon said it had agreed to sell lip balm brand ChapStick to a company owned by private equity firm Yellow Wood Partners.

Sir Dave Lewis Named Operating Advisor To CD&R Funds

US investment firm Clayton, Dubilier & Rice (CD&R) has appointed Sir Dave Lewis as an operating advisor to CD&R funds.

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

Haleon Raises Annual Organic Revenue Growth Forecast On Steady Demand

Haleon has raised its forecast for annual organic revenue growth, as the consumer healthcare company is confident that demand for its oral and respiratory...

Sensodyne Toothpaste-Maker Haleon Planning Job Cuts - The Guardian

Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Gu...

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...